HIV Diagnostics Market Key Highlights:
- Market Size (2024): USD 3,498 Million
- Projected Market Size (2034): USD 7,277 Million
- CAGR (2024-2034): 7.6%
Pricing Analysis:
- Price Growth
- Regional Variations
Market Historic Sales
- Total sales volume, year-over-year growth, product categories, and market share.
Revenue Estimation
- Forecasting future revenues based on historical data, market trends, and economic indicators.
Sales by Region
- Breakdown of sales performance across different geographical areas.
Revenue by Manufacturer
- Analysis of revenue contributions from different manufacturers in the market.
HIV Diagnostics Market Definition
The HIV diagnostics market focuses on developing, producing and distribution of diagnostics tools for monitoring HIV viruses. The market for HIV diagnostics is expected to propel due to the growing rates of infected patients and the high percentage of untreated infections. Awareness and testing are important in combating the epidemic as well as in the healthcare of individuals. The growing need for HIV diagnostics has been related to the need to recognize certain types of viruses that cause acquired immune deficiency syndrome (AIDS). HIV testing is performed using either serum, saliva, or urine samples to check if the virus is present.
Nevertheless, there are challenges associated with market penetration, such as the high price of nucleic acid testing (NAT) and the fact that there are no NAT prerequisites in developing economies. The desire and the ability of healthcare facilities to acquire and use NAT technologies diminishes when there is no pressure or financial assistance, from either the state or global health agencies, which unfortunately hampers the response towards the control and reduction of the virus transmission.
Advanced technology is further propelling the growth of the market. The growth of the market can be attributed to the rising awareness levels on HIV, the increasing measures aimed at enhancing confidentiality of testing, improved availability of the tests, and counseling services.
HIV Diagnostics Market Segmentation:
By Product
- Consumables
- Instruments
- Software & Services
By Test
- Antibody Tests
- Viral Load Tests
- CD4 Tests
- Others
By End User
- Diagnostic Laboratories
- Hospitals
- Others
HIV Diagnostics Market Companies:
- F. Hoffmann-La Roche Ltd
- Abbott Laboratories
- Danaher Corporation
- Thermo-Fisher Scientific Inc
- Bristol-Myers Squibb Company
- Janssen Global Services, LLC
- Gilead Sciences, Inc.
- Merck & Co. Inc.
- QIAGEN
- Apogee Flow Systems
- Point Care
- Zyomtronix, Inc.
For any questions about this dataset or to discuss customization options, please write to us at sales@statifacts.com
